Matches in SemOpenAlex for { <https://semopenalex.org/work/W2068842874> ?p ?o ?g. }
Showing items 1 to 91 of
91
with 100 items per page.
- W2068842874 endingPage "61" @default.
- W2068842874 startingPage "61" @default.
- W2068842874 abstract "Objective: This study was aimed to compare the efficacy between long-acting beta 2-agonists and leukotriene receptor antagonists as add-on therapy to inhaled corticosteroids in moderate persistent asthma. Materials and Methods: This study was carried out at the Kovai Medical Center and Hospital, in Coimbatore. The study protocol was approved by the Ethics committee of the Kovai Medical Center and Hospital. Patients with asthma in the outpatient respiratory department were included in the study. Out of 100 patients, 46 patients received the combination product, budesonide 400 µg and formoteral fumarate 6µg as an inhaled dose and this group was named group A. The other group had 44 patients and was prescribed oral montelukast 10 mg along with budesonide 400 µg as an inhaled dose. This group was called group B. The parameters recorded included, pulmonary function test reports, MBDS (Modified Borg's Dyspnea Scale). The quality of life was evaluated both before and after the treatment period by the SGRQ (St. George's Respiratory Questionnaire). Results: The two groups, group A and group B were assessed for pulmonary activity. The initial results of the score (MBDS) were 3.3 ± 0.12 and 3.2 ± 0.13 for group A and group B, respectively. Scores were reduced to 0.19 ± 0.08 and 0.35 ± 0.08 respectively after one month of therapy. For group A, the mean values for forced expiratory volume in one second (FEV 1 ), peak expiratory flow (PEF) and forced vital capacity (FVC) before treatment were 1.4 ± 0.1, 3.2 ± 0.33 and 1.8 ± 0.18, respectively, whereas after treatment the values were 2 ± 0.14, 5.2 ± 0.41 and 2.4 ± 0.17. For group B the mean FEV 1 , PEV and FVC, before and after therapy were 1.2 ± 0.1 - 1.8 ± 0.17; 3.1 ± 0.3 - 5.4 ± 0.42; 1.8 ± 0.17 - 2.4 ± 0.22 respectively. Conclusions: In our conclusion, we suggest that a montelukast is as effective as formoterol fumarate for add-on therapy to budesonide in moderate persistent asthma. Hence, montelukast can be considered an alternate therapeutic option for such patients. The results of this study are expected to provide physicians with clinical evidence to help them make a rational decision when treating patients with moderate persistent asthma." @default.
- W2068842874 created "2016-06-24" @default.
- W2068842874 creator A5008707489 @default.
- W2068842874 creator A5010956888 @default.
- W2068842874 creator A5060635853 @default.
- W2068842874 date "2014-01-01" @default.
- W2068842874 modified "2023-09-24" @default.
- W2068842874 title "Comparison of efficacy between long-acting beta 2-agonists (formoterol fumarate) and leukotriene-receptor antagonists (montelukast) as add-on therapy to inhaled corticosteroids (budesonide) in moderate persistent asthma" @default.
- W2068842874 cites W1986357824 @default.
- W2068842874 cites W1995129283 @default.
- W2068842874 cites W2002796983 @default.
- W2068842874 cites W2022551713 @default.
- W2068842874 cites W2023690878 @default.
- W2068842874 cites W2032414191 @default.
- W2068842874 cites W2044201396 @default.
- W2068842874 cites W2117833280 @default.
- W2068842874 cites W2278769340 @default.
- W2068842874 cites W2281938476 @default.
- W2068842874 cites W2313479281 @default.
- W2068842874 cites W2328990695 @default.
- W2068842874 cites W2440788877 @default.
- W2068842874 cites W285127643 @default.
- W2068842874 doi "https://doi.org/10.4103/2045-080x.132649" @default.
- W2068842874 hasPublicationYear "2014" @default.
- W2068842874 type Work @default.
- W2068842874 sameAs 2068842874 @default.
- W2068842874 citedByCount "1" @default.
- W2068842874 countsByYear W20688428742016 @default.
- W2068842874 crossrefType "journal-article" @default.
- W2068842874 hasAuthorship W2068842874A5008707489 @default.
- W2068842874 hasAuthorship W2068842874A5010956888 @default.
- W2068842874 hasAuthorship W2068842874A5060635853 @default.
- W2068842874 hasConcept C126322002 @default.
- W2068842874 hasConcept C165637977 @default.
- W2068842874 hasConcept C2776042228 @default.
- W2068842874 hasConcept C2776136866 @default.
- W2068842874 hasConcept C2776322731 @default.
- W2068842874 hasConcept C2776719499 @default.
- W2068842874 hasConcept C2777714996 @default.
- W2068842874 hasConcept C2779871671 @default.
- W2068842874 hasConcept C2780212800 @default.
- W2068842874 hasConcept C3018587741 @default.
- W2068842874 hasConcept C42219234 @default.
- W2068842874 hasConcept C55520419 @default.
- W2068842874 hasConcept C71924100 @default.
- W2068842874 hasConcept C75603125 @default.
- W2068842874 hasConceptScore W2068842874C126322002 @default.
- W2068842874 hasConceptScore W2068842874C165637977 @default.
- W2068842874 hasConceptScore W2068842874C2776042228 @default.
- W2068842874 hasConceptScore W2068842874C2776136866 @default.
- W2068842874 hasConceptScore W2068842874C2776322731 @default.
- W2068842874 hasConceptScore W2068842874C2776719499 @default.
- W2068842874 hasConceptScore W2068842874C2777714996 @default.
- W2068842874 hasConceptScore W2068842874C2779871671 @default.
- W2068842874 hasConceptScore W2068842874C2780212800 @default.
- W2068842874 hasConceptScore W2068842874C3018587741 @default.
- W2068842874 hasConceptScore W2068842874C42219234 @default.
- W2068842874 hasConceptScore W2068842874C55520419 @default.
- W2068842874 hasConceptScore W2068842874C71924100 @default.
- W2068842874 hasConceptScore W2068842874C75603125 @default.
- W2068842874 hasIssue "2" @default.
- W2068842874 hasLocation W20688428741 @default.
- W2068842874 hasOpenAccess W2068842874 @default.
- W2068842874 hasPrimaryLocation W20688428741 @default.
- W2068842874 hasRelatedWork W2037864197 @default.
- W2068842874 hasRelatedWork W2085457639 @default.
- W2068842874 hasRelatedWork W2093334569 @default.
- W2068842874 hasRelatedWork W2104692335 @default.
- W2068842874 hasRelatedWork W2133198403 @default.
- W2068842874 hasRelatedWork W2135150318 @default.
- W2068842874 hasRelatedWork W2156263705 @default.
- W2068842874 hasRelatedWork W2347998993 @default.
- W2068842874 hasRelatedWork W2371848484 @default.
- W2068842874 hasRelatedWork W2392871984 @default.
- W2068842874 hasRelatedWork W2408094651 @default.
- W2068842874 hasRelatedWork W2523116654 @default.
- W2068842874 hasRelatedWork W2776760314 @default.
- W2068842874 hasRelatedWork W2801040726 @default.
- W2068842874 hasRelatedWork W3028747444 @default.
- W2068842874 hasRelatedWork W3029518330 @default.
- W2068842874 hasRelatedWork W3152211761 @default.
- W2068842874 hasRelatedWork W3177086985 @default.
- W2068842874 hasRelatedWork W1916246392 @default.
- W2068842874 hasRelatedWork W2943834256 @default.
- W2068842874 hasVolume "5" @default.
- W2068842874 isParatext "false" @default.
- W2068842874 isRetracted "false" @default.
- W2068842874 magId "2068842874" @default.
- W2068842874 workType "article" @default.